Andrey Petrov, PhD
Andrei is the Managing Director focussing on Pharma and Biotech investments. He has over 15 years of scientific experience, with over 10 years in biopharma and investments. Andrei has served as a board member in seven US and European companies, several of which were publicly listed on the NASDAQ. As the CEO of Inbio Ventures, since 2013 Andrei has built a portfolio of 10 US and two EU companies syndicated with top venture funds and executed five exits. As the CSO of International biotechnology centre Generium in 2011-2014, he created an R&D portfolio of over 40 products. Andrei developed the first biosimilars in Eastern Europe, including the blood clotting factors VII, VIII and IX, with factor VII sales standing at $70m. Andrei has a PhD in Chemistry, then postdoc experience at Institut Gustave Roussy.